Aerin Medical Inc.
Aerin Medical offers VivAer for nasal airway obstruction treatment and RhinAer for chronic runny nose treatment. Lasting relief when other solutions fall short.
7 additional officers and directors, 3 additional relationships, 2 additional investors
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- 3 investorsnamed
3 investors on record.
The investors already on the cap table shape who leads the next round.
- 7 directorsboard
7 directors on record from Form D filings and board-seat attributions.
The board is who decides on the next round and on a sale.
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 2
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 3
Financing history
- Dec 13, 2024Form D equity offering · $32.5M (form d sold) · 23 investorsQuesta Capital Management, L.L.C. via Ryan David DrantFact Form D · “Aerin Medical Inc. filed Form D: $32,477,189 sold of $32,815,188, Other Health Care”
- Apr 28, 2022Form D equity offering · $34.9M (form d sold)Questa Capital Management, L.L.C. via Ryan David DrantFact Form D · “Aerin Medical Inc. Form D, first filed 2022-05-04”
Investors on record
- Questa Capital Management, L.L.C. portfolio listing Fact questacapital.com
- Ares Management LLC portfolio listing Fact aerinmedical.com
- Orbimed Advisors LLC portfolio listing Fact aerinmedical.com
Ownership and outcomes
How these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.Listed on 3 firm portfolio pages; none states an outcome (acquired, public, exited or active). DFX does not assume the company is active.
Evidence: 3 listingseach firm's own card, as read
- Status not stated on Questa Capital Management, L.L.C. · the firm's card prints no outcome · read Oct 1, 2026 questacapital.com“Aerin Medical”
- Status not stated on Ares Management LLC · the firm's card prints no outcome · read Sep 26, 2026 aerinmedical.com“The $32.5 million equity financing was led by all of Aerin's major investors: KCK MedTech, Questa Capital, OrbiMed, and Ally Bridge Group, with new participation by Ares Management Credit funds, which”
- Status not stated on Orbimed Advisors LLC · the firm's card prints no outcome · read Sep 26, 2026 aerinmedical.com“The $32.5 million equity financing was led by all of Aerin's major investors: KCK MedTech, Questa Capital, OrbiMed, and Ally Bridge Group, with new participation by Ares Management Credit funds, which”
Credit relationships
How a loan is matchedA BDC reports its loans by borrower name. A position shows here only when the match passed a precision gate (a hand-labelled sample was 29 of 30 correct); the tier and confidence are printed on each row. Amounts are the lender’s reported position, never a round.- ARES CAPITAL CORP preferred, equity
- ARES STRATEGIC INCOME FUND preferred, equity
People
- Andre Cheng Executive Officer sec.gov
- Derrick Sung Executive Officer sec.gov
- Irina Ridley Executive Officer sec.gov
- David Thrower Director Fact
- Gregory Garfield Director Fact
Show all 6 officers and directors
- Andre Cheng Executive Officer sec.gov
- Derrick Sung Executive Officer sec.gov
- Irina Ridley Executive Officer sec.gov
- David Thrower Director Fact
- Gregory Garfield Director Fact
- Kevin Reilly Director Fact
Timeline
- Dec 30, 2024Aerin Medical Inc. filed Form D: $32,477,189 sold of $32,815,188, Other Health CareForm D filed Fact Form D
Evidence
Every observation on this company
- Description: Sep 26, 2026 Fact
- Entity type: Corporation Dec 30, 2024 Fact Form D
- Form D industry group: Other Health Care Dec 30, 2024 Fact Form D
- Amendment: false Dec 30, 2024 Fact Form D
- Revenue range (Form D): Decline to Disclose Dec 30, 2024 Fact Form D
- Incorporated: overFiveYears Dec 30, 2024 Fact Form D
- Investors named on site: 2 Sep 26, 2026 Fact
- Jurisdiction: Delaware Dec 30, 2024 Fact Form D
- Amount sold (Form D): $32.5M Dec 30, 2024 Fact Form D
- Offering amount (Form D): $32.8M Dec 30, 2024 Fact Form D
- Exemptions: 06b Dec 30, 2024 Fact Form D
- First sale: 2024-12-13 Dec 30, 2024 Fact Form D
- Investors (Form D): 23 Dec 30, 2024 Fact Form D
- Minimum investment (Form D): 0 Dec 30, 2024 Fact Form D
- Securities offered: equity Dec 30, 2024 Fact Form D
- Office address: Dec 30, 2024 Fact Form D
- Listed on portfolio page: Oct 1, 2026 Fact
- Listed on portfolio page: Sep 16, 2026 Fact
- Listed on portfolio page: Sep 15, 2026 Fact
- Website status: ok Sep 26, 2026 Fact
- Site title: Sep 26, 2026 Fact
Relationships across DFX
on 2 other DFX graphs · 27 capital paths
Aerin Medical Inc. is the same institution as 2 records in Private Equity and Private Credit.
DFX found 2 relationships across 2 datasets
Which record it is in each graph, what it is called there, and how the two were matched.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Checking your plan…
Aerin Medical Inc. sits on 27 traced paths of capital across the graphs.
DFX traced 27 paths of capital through this record
Every record on each path, what it committed or lent, and as of when.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Derived from allocator disclosures, BDC schedules and SEC filings; confidence is the weakest hop.
Checking your plan…
Record history
- Form D filed2024-12-30source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.